Elanco Animal Health (ELAN) Common Equity (2017 - 2026)

Elanco Animal Health has disclosed Common Equity across 10 years of filings, most recently posting $6.5 billion for Q1 2026.

• Common Equity for Q1 2026 came in at $6.5 billion, up 2.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 billion (up 2.31% YoY), and the FY2025 annual result was $6.5 billion, up 7.4% from the prior year.
• Common Equity came in at $6.5 billion for Q1 2026 at Elanco Animal Health, down from $6.5 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $7.6 billion in Q1 2022 to a low of $5.9 billion in Q2 2024.
• The 5-year median for Common Equity is $6.5 billion (2025), against an average of $6.7 billion.
• Across the five-year window, Common Equity dropped 19.92% in 2024 and increased 14.02% in 2025, its largest moves.
• Elanco Animal Health's Common Equity stood at $7.3 billion in 2022, then dropped by 14.62% to $6.2 billion in 2023, then dropped by 2.04% to $6.1 billion in 2024, then climbed by 7.4% to $6.5 billion in 2025, then dropped by 0.72% to $6.5 billion in 2026.
• The last three Common Equity figures came in at $6.5 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.